Related Experiment Videos
Effects of antihypertensive drugs on plasma lipids
1First Department of Medicine, National Defense Medical College, Tokorozawa, Japan.
Insights
Systemic hypertension and plasma lipoprotein disorders are key risk factors for atherosclerotic coronary artery disease. Antihypertensive drugs may alter blood lipids, potentially impacting cardiovascular protection.
Area of Science:
- Cardiology
- Metabolic Disorders
- Pharmacology
Background:
- Systemic hypertension and plasma lipoprotein disorders are significant risk factors for atherosclerotic coronary artery diseases.
- Antihypertensive medications can influence blood lipid profiles, potentially counteracting their cardiovascular benefits.
- Understanding hyperlipoproteinemia prevalence in Japan is crucial for assessing atherosclerotic vascular disease risk.
Purpose of the Study:
- To investigate the effects of commonly prescribed antihypertensive drugs on blood lipids and apolipoproteins.
- To discuss the prevalence of hyperlipoproteinemia in the Japanese population.
- To examine the relationship between lipid changes and atherosclerotic vascular disease risk.
Main Methods:
- Review of existing data on antihypertensive drug effects on blood lipids.
- Analysis of prevalence data for hyperlipoproteinemia in Japanese individuals.
- Correlation analysis between lipid profiles and atherosclerotic vascular disease frequency.
Main Results:
- Commonly prescribed antihypertensive drugs have been shown to alter blood lipid and apolipoprotein levels.
- The prevalence of various hyperlipoproteinemia types in Japan is detailed.
- Potential impact of drug-induced lipid changes on the protective benefits of hypertension treatment is discussed.
Conclusions:
- Antihypertensive drug-induced dyslipidemia may compromise the cardiovascular benefits of blood pressure management.
- Further research is needed to optimize antihypertensive therapies for patients with lipid disorders.
- Tailoring treatment strategies is essential for managing atherosclerotic disease risk in hypertensive populations.
Abstract:
Among the risk factors associated with atherosclerotic coronary artery diseases, systemic hypertension and disorders of plasma lipoproteins and apoproteins are very important. Blood lipid changes have been reported with a number of antihypertensive drugs and may conceivably reduce the coronary artery disease-protective benefits of blood pressure reduction. The prevalence of various types of hyperlipoproteinemia among Japanese is discussed, with special reference to the frequency of atherosclerotic vascular diseases. Data concerning the effects of commonly prescribed antihypertensive drugs on blood lipids and apolipoproteins are reported.